Five-Year Outcomes of the Partial Oral Treatment of Endocarditis (POET) Trial

Research output: Contribution to journalComment/debateResearchpeer-review

Standard

Five-Year Outcomes of the Partial Oral Treatment of Endocarditis (POET) Trial. / Rosenvinge, Flemming; Helweg-Larsen, Jannik; Fosbol, Emil L.; Kober, Lars; Torp-Pedersen, Christian; Tonder, Niels; Moser, Claus; Iversen, Kasper; Bundgaard, Henning.

In: New England Journal of Medicine, Vol. 386, No. 6, 10.02.2022, p. 601-602.

Research output: Contribution to journalComment/debateResearchpeer-review

Harvard

Rosenvinge, F, Helweg-Larsen, J, Fosbol, EL, Kober, L, Torp-Pedersen, C, Tonder, N, Moser, C, Iversen, K & Bundgaard, H 2022, 'Five-Year Outcomes of the Partial Oral Treatment of Endocarditis (POET) Trial', New England Journal of Medicine, vol. 386, no. 6, pp. 601-602. https://doi.org/10.1056/NEJMc2114046

APA

Rosenvinge, F., Helweg-Larsen, J., Fosbol, E. L., Kober, L., Torp-Pedersen, C., Tonder, N., Moser, C., Iversen, K., & Bundgaard, H. (2022). Five-Year Outcomes of the Partial Oral Treatment of Endocarditis (POET) Trial. New England Journal of Medicine, 386(6), 601-602. https://doi.org/10.1056/NEJMc2114046

Vancouver

Rosenvinge F, Helweg-Larsen J, Fosbol EL, Kober L, Torp-Pedersen C, Tonder N et al. Five-Year Outcomes of the Partial Oral Treatment of Endocarditis (POET) Trial. New England Journal of Medicine. 2022 Feb 10;386(6):601-602. https://doi.org/10.1056/NEJMc2114046

Author

Rosenvinge, Flemming ; Helweg-Larsen, Jannik ; Fosbol, Emil L. ; Kober, Lars ; Torp-Pedersen, Christian ; Tonder, Niels ; Moser, Claus ; Iversen, Kasper ; Bundgaard, Henning. / Five-Year Outcomes of the Partial Oral Treatment of Endocarditis (POET) Trial. In: New England Journal of Medicine. 2022 ; Vol. 386, No. 6. pp. 601-602.

Bibtex

@article{dbeeb7d621d6491f98d55b0ef88a47ce,
title = "Five-Year Outcomes of the Partial Oral Treatment of Endocarditis (POET) Trial",
author = "Flemming Rosenvinge and Jannik Helweg-Larsen and Fosbol, {Emil L.} and Lars Kober and Christian Torp-Pedersen and Niels Tonder and Claus Moser and Kasper Iversen and Henning Bundgaard",
year = "2022",
month = feb,
day = "10",
doi = "10.1056/NEJMc2114046",
language = "English",
volume = "386",
pages = "601--602",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachusetts Medical Society",
number = "6",

}

RIS

TY - JOUR

T1 - Five-Year Outcomes of the Partial Oral Treatment of Endocarditis (POET) Trial

AU - Rosenvinge, Flemming

AU - Helweg-Larsen, Jannik

AU - Fosbol, Emil L.

AU - Kober, Lars

AU - Torp-Pedersen, Christian

AU - Tonder, Niels

AU - Moser, Claus

AU - Iversen, Kasper

AU - Bundgaard, Henning

PY - 2022/2/10

Y1 - 2022/2/10

U2 - 10.1056/NEJMc2114046

DO - 10.1056/NEJMc2114046

M3 - Comment/debate

C2 - 35139280

VL - 386

SP - 601

EP - 602

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 6

ER -

ID: 315258855